Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recursion Pharmaceuticals, Inc. - Class A Common Stock
(NQ:
RXRX
)
5.280
+0.070 (+1.34%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
What Analysts Are Saying About Recursion Pharmaceuticals Stock
Today 14:00 EDT
Via
Benzinga
Is the Market Bullish or Bearish on Recursion Pharmaceuticals?
June 26, 2025
Via
Benzinga
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health
June 17, 2025
Issued on behalf of Avant Technologies Inc. Vancouver, BC – June 17, 2025 – USA News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Expert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 Analysts
June 16, 2025
Via
Benzinga
Earnings Scheduled For May 5, 2025
May 05, 2025
Via
Benzinga
Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?
June 16, 2025
Via
The Motley Fool
Topics
Animal Testing
Artificial Intelligence
Intellectual Property
Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
June 10, 2025
Via
The Motley Fool
Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening?
June 10, 2025
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher and trending. The company on Tuesday announced a reduction in personnel and infrastructure aimed at extending its cash runway.
Via
Benzinga
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
June 10, 2025
Via
Benzinga
Recursion Pharmaceuticals Stock Surges After Company Lays Off 20% Workforce: Retail Predicts ‘Blue Skies’ Ahead
June 10, 2025
The company now expects its projected cash runway to extend into the fourth quarter of 2027.
Via
Stocktwits
Topics
Artificial Intelligence
Workforce
Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?
June 08, 2025
Via
Benzinga
Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT
June 06, 2025
Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict...
Via
Benzinga
Topics
Artificial Intelligence
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
June 06, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
May 30, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
3 Monster Stocks to Hold for the Next 10 Years
May 26, 2025
A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.
Via
The Motley Fool
Topics
Energy
8 Health Care Stocks With Whale Alerts In Today's Session
May 23, 2025
Via
Benzinga
These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio
May 22, 2025
While institutional money managers have released their Q1 holdings, so has the heart and soul of the AI revolution, NVIDIA. See which six stocks NVIDIA owns.
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?
May 12, 2025
Via
The Motley Fool
Topics
Animal Testing
Artificial Intelligence
2 Top Artificial Intelligence (AI) Stocks to Buy Right Now
May 11, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Why Recursion Pharmaceuticals Stock Plummeted 24% This Week
May 09, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
Why Recursion Pharmaceuticals Stock Is Plummeting Today
May 06, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
Recursion to Participate in Upcoming Investor Conferences
May 06, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Why Recursion Pharmaceuticals Stock Was Getting Mashed on Monday
May 05, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
May 05, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Retail Traders Bearish On Recursion Pharma Ahead of Q1 Results Despite Positive Tupelo Trial Data
May 04, 2025
Traders flagged a key technical level at $4.65 and raised concerns over an outlier patient in the Tupelo trial, with attention now turning to management’s commentary during the earnings call.
Via
Stocktwits
Topics
Earnings
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
May 04, 2025
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
How Do Investors Really Feel About Recursion Pharmaceuticals?
May 01, 2025
Via
Benzinga
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th
April 28, 2025
Company to host public (L)earnings call on May 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT
From
Recursion Pharmaceuticals
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.